Scientists Discover the Brain Enzyme Behind Childhood Trauma's Lasting Damage

A Scar You Can't See

Experiencing severe stress during childhood can make a person more vulnerable to anxiety, depression, and other mood disorders when faced with hardships as an adult. That much has long been suspected. What scientists didn't know — until now — was exactly how that vulnerability gets wired into the brain at a molecular level. A study published on August 7, 2026, in the journal Neuron by researchers at Washington University School of Medicine in St. Louis and Princeton University may have finally found the answer.

Researchers at Washington University School of Medicine in St. Louis and Princeton University uncovered how trauma early in life can leave a lasting effect on the brain. Their focus: dopamine-producing neurons — the brain cells responsible for processing rewards, motivation, and how we respond to adversity. What they found inside those cells was a kind of biological scar, one that quietly reshapes how a person handles stress for the rest of their life.

The Enzyme at the Center of It All

The study identified that childhood trauma increases levels of the enzyme SETD7 within dopamine-producing neurons of the ventral tegmental area (VTA). To understand what that means, it helps to picture how DNA works inside a cell. Study senior author Catherine Jensen Peña, an assistant professor at Princeton University's Neuroscience Institute, explained that inside cells, DNA is coiled like a slinky. The DNA coils are wrapped around histone proteins that help determine how tightly or loosely the coil is wound. When the genetic "slinky" is compressed, its genes are turned off. As the DNA slinky stretches and opens, genes are more easily accessible to be turned on.

More SETD7 leads to more chemical tags designated as H3K4me1 — chemical tags that label DNA as ready for uncoiling inside the VTA neurons. What that essentially does is make it easier for genes in these dopamine-producing cells to be turned on in the future. The result is a brain that stays perpetually primed for stress — a hair trigger that never fully resets. In mice, early-life stress increased SETD7 in dopamine neurons, elevating H3K4me1 marks and loosening chromatin at stress-responsive genes. This persistent epigenetic state increased adult neuronal reactivity and anxiety-like behavior.

Blocking the Switch

The researchers didn't just identify the problem — they tested whether it could be reversed. The researchers then artificially boosted SETD7 in young, stress-free mice. Even without early-life stress, these mice grew up with a stretched-open DNA structure in their dopamine-producing brain cells, making it easier to turn on the genes that respond to stress. Such mice had a lower tolerance for stress in adulthood. This confirmed that SETD7 alone — not the stressful experience itself — was driving the lasting damage.

When the researchers blocked the SETD7 enzyme from adding too much of the H3K4me1 tag after early-life stress, the slinky remained closed, shielding mice from becoming hypersensitive to stress later in life. Despite experiencing both early-life and adult stress, mice with their SETD7 levels dampened were able to remain as social and exploratory as unstressed mice, and their dopamine neurons were active at normal levels. In other words, blocking the enzyme essentially erased the biological footprint of early trauma.

Why This Discovery Matters

The stakes here extend well beyond the lab. Repeated exposure to a broad variety of traumas in early childhood places particular strain on mental health and is correlated with illicit substance use disorders, depression, obesity, and increases in suicidal ideation into adulthood. Due to recurrent stress response activation before the age of 18, children and young people with a history of multiple ACEs are at higher risk of developing neuropsychiatric and emotional disorders, including PTSD, anxiety or depression, ADHD, and schizophrenia.

According to Peña, "There are currently no treatments for what early-life stress does to the brain, partially because we have not had a clear picture of what molecular mechanisms to target." That picture is now coming into focus. With SETD7 identified as a concrete biological target, researchers can begin exploring drugs or therapies designed to modulate the enzyme — potentially offering a new class of treatments for the millions of adults whose mental health struggles trace back to what happened to them as children. The question now is how quickly that science can be translated from mice to medicine.